Article Details
Retrieved on: 2019-12-02 22:48:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Gene therapy concern Audentes Therapeutics Inc (NASDAQ:BOLD) has more than doubled this morning, surging 104.9% to trade at $58.63, on news ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here